scispace - formally typeset
L

Lu Fanghong

Researcher at Peking Union Medical College

Publications -  8
Citations -  2965

Lu Fanghong is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Cohort study & Epidemiology. The author has an hindex of 5, co-authored 8 publications receiving 2291 citations.

Papers
More filters
Journal ArticleDOI

Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

Mahshid Dehghan, +355 more
- 04 Nov 2017 - 
TL;DR: High carbohydrate intake was associated with higher risk of total mortality, whereas total fat and individual types of fat were related to lower total mortality.
Journal ArticleDOI

Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study

Victoria Miller, +355 more
- 04 Nov 2017 - 
TL;DR: Higher total fruit, vegetable, and legume intake was inversely associated with major cardiovascular disease, myocardial infarction, cardiovascular mortality, non-cardiovascular mortality, and total mortality in the models adjusted for age, sex, and centre (random effect).
Journal ArticleDOI

Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study.

Andrew Mente, +427 more
TL;DR: Simulations suggest that ApoB-to-ApoA1 ratio probably provides the best overall indication of the effect of saturated fatty acids on cardiovascular disease risk among the markers tested, which is at odds with current recommendations to reduce total fat and saturated fats.
Journal ArticleDOI

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Marjan W. Attaei, +412 more
TL;DR: The availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development, are assessed.